• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃塞俄比亚成年人糖尿病视网膜病变的患病率及其相关危险因素:系统评价和荟萃分析。

Prevalence of diabetic retinopathy and its associated risk factors among adults in Ethiopia: a systematic review and meta-analysis.

机构信息

Department of Public Health, College of Medical and Health Science, Samara University, Semera, Ethiopia.

出版信息

Sci Rep. 2024 Nov 16;14(1):28266. doi: 10.1038/s41598-024-78596-9.

DOI:10.1038/s41598-024-78596-9
PMID:39550444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11569147/
Abstract

Diabetic retinopathy is a complication of diabetes mellitus and a leading cause of blindness and visual impairment globally. Limited information existed on the epidemiology of diabetic retinopathy at the national level in Ethiopia. Thus, the objective of this review was to determine the pooled prevalence of diabetic retinopathy and its associated risk factors in Ethiopia. A systematic review and meta-analysis was conducted using previous primary studies that were found in electronic databases such as Web of Science, Scopus, PubMed, CINHAL, Google Scholar, and online African journals. We evaluated the quality of the included studies using the Newcastle-Ottawa Assessment Scale. The random-effects model was applied because heterogeneity was expected. I-Square and the Cochrane Q statistics were used to evaluate heterogeneity. Publication bias was examined using Egger's test and a funnel plot. A random-effect meta-analysis was applied to pool the odds ratios of risk factors to determine the association between the independent and dependent variables. After 598 articles were found, 22 studies that met the eligibility requirements were included. The pooled prevalence of retinopathy among patients with diabetes in Ethiopia was 24.35% (95% CI: 18.88-29.83), with considerable heterogeneity (I = 98.18%, p < 0.001). Ten years and longer with diabetes (AOR = 4.36, 95% CI: 1.71-7.01), hypertension (AOR = 2.54, 95% CI: 1.45-3.63), poor glycemic control (AOR = 3.83, 95% CI: 1.62-6.04), and positive proteinuria (AHR = 1.55, 95% CI: 1.02-2.07) were risk factors for diabetic retinopathy. Retinopathy affects one in four patients with diabetes. Diabetic patients with longer duration, hypertension, poor glycemic control, and positive proteinuria should receive special care.

摘要

糖尿病视网膜病变是糖尿病的一种并发症,是全球范围内导致失明和视力损害的主要原因。在埃塞俄比亚,关于国家层面糖尿病视网膜病变的流行病学信息有限。因此,本综述的目的是确定埃塞俄比亚糖尿病视网膜病变的患病率及其相关危险因素的汇总患病率。我们使用之前在电子数据库(如 Web of Science、Scopus、PubMed、CINHAL、Google Scholar 和在线非洲期刊)中找到的原始研究进行了系统综述和荟萃分析。我们使用纽卡斯尔-渥太华评估量表评估了纳入研究的质量。由于预计存在异质性,因此应用了随机效应模型。我们使用 I 平方和 Cochrane Q 统计量评估异质性。使用 Egger 检验和漏斗图检查发表偏倚。应用随机效应荟萃分析汇总风险因素的优势比,以确定独立和依赖变量之间的关联。在发现 598 篇文章后,纳入了 22 项符合入选标准的研究。埃塞俄比亚糖尿病患者视网膜病变的总体患病率为 24.35%(95%CI:18.88-29.83),存在很大的异质性(I=98.18%,p<0.001)。糖尿病病程 10 年及以上(AOR=4.36,95%CI:1.71-7.01)、高血压(AOR=2.54,95%CI:1.45-3.63)、血糖控制不佳(AOR=3.83,95%CI:1.62-6.04)和蛋白尿阳性(AHR=1.55,95%CI:1.02-2.07)是糖尿病视网膜病变的危险因素。每四名糖尿病患者中就有一名患有视网膜病变。病程较长、患有高血压、血糖控制不佳和蛋白尿阳性的糖尿病患者应接受特别护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/766c3fee65af/41598_2024_78596_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/afda7eefd6de/41598_2024_78596_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/590c08ffad5d/41598_2024_78596_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/e62a9550a6cd/41598_2024_78596_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/6b322195077e/41598_2024_78596_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/5509db057720/41598_2024_78596_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/9901139dc24a/41598_2024_78596_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/47ec0bac8202/41598_2024_78596_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/0fd9739e6e82/41598_2024_78596_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/d47648ec994e/41598_2024_78596_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/3255708106cf/41598_2024_78596_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/7a6212cbe6c4/41598_2024_78596_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/87abd7971654/41598_2024_78596_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/6634431198e7/41598_2024_78596_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/766c3fee65af/41598_2024_78596_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/afda7eefd6de/41598_2024_78596_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/590c08ffad5d/41598_2024_78596_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/e62a9550a6cd/41598_2024_78596_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/6b322195077e/41598_2024_78596_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/5509db057720/41598_2024_78596_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/9901139dc24a/41598_2024_78596_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/47ec0bac8202/41598_2024_78596_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/0fd9739e6e82/41598_2024_78596_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/d47648ec994e/41598_2024_78596_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/3255708106cf/41598_2024_78596_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/7a6212cbe6c4/41598_2024_78596_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/87abd7971654/41598_2024_78596_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/6634431198e7/41598_2024_78596_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5248/11569147/766c3fee65af/41598_2024_78596_Fig14_HTML.jpg

相似文献

1
Prevalence of diabetic retinopathy and its associated risk factors among adults in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚成年人糖尿病视网膜病变的患病率及其相关危险因素:系统评价和荟萃分析。
Sci Rep. 2024 Nov 16;14(1):28266. doi: 10.1038/s41598-024-78596-9.
2
Determinants of diabetic retinopathy in Ethiopia: A systematic review and meta-analysis.埃塞俄比亚糖尿病视网膜病变的决定因素:系统评价和荟萃分析。
PLoS One. 2023 Jun 8;18(6):e0286627. doi: 10.1371/journal.pone.0286627. eCollection 2023.
3
Determinants of diabetic nephropathy among diabetic patients in Ethiopia: Systematic review and meta-analysis.埃塞俄比亚糖尿病患者中糖尿病肾病的决定因素:系统评价和荟萃分析。
PLoS One. 2024 Feb 2;19(2):e0297082. doi: 10.1371/journal.pone.0297082. eCollection 2024.
4
Diabetic retinopathy in Ethiopia: A systematic review and meta-analysis.埃塞俄比亚的糖尿病视网膜病变:一项系统评价与荟萃分析。
Diabetes Metab Syndr. 2019 May-Jun;13(3):1885-1891. doi: 10.1016/j.dsx.2019.04.016. Epub 2019 Apr 17.
5
Prevalence of diabetic retinopathy among diabetic patients in Northwest Ethiopia-A cross sectional hospital based study.埃塞俄比亚西北部糖尿病患者中糖尿病视网膜病变的患病率-一项基于医院的横断面研究。
PLoS One. 2022 Jan 21;17(1):e0262664. doi: 10.1371/journal.pone.0262664. eCollection 2022.
6
Diabetic dyslipidemia and its predictors among people with diabetes in Ethiopia: systematic review and meta-analysis.埃塞俄比亚糖尿病患者的血脂异常及其预测因素:系统评价和荟萃分析。
Syst Rev. 2024 Jul 20;13(1):190. doi: 10.1186/s13643-024-02593-2.
7
Glycated hemoglobin A1C level and the risk of diabetic retinopathy in Africa: A systematic review and meta-analysis.糖化血红蛋白 A1C 水平与非洲糖尿病视网膜病变风险的关系:系统评价和荟萃分析。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1941-1949. doi: 10.1016/j.dsx.2020.10.003. Epub 2020 Oct 7.
8
Magnitude of postpartum hemorrhage and associated factors among women who gave birth in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚产妇产后出血的严重程度及其相关因素:系统评价和荟萃分析。
Reprod Health. 2022 Sep 21;19(1):194. doi: 10.1186/s12978-022-01498-4.
9
Determinants of poor glycemic control among type 2 diabetes in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚 2 型糖尿病患者血糖控制不佳的决定因素:系统评价和荟萃分析。
Front Public Health. 2024 Feb 5;12:1256024. doi: 10.3389/fpubh.2024.1256024. eCollection 2024.
10
Prevalence of completion of maternity continuum of care and its associated factors in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚母婴连续照护完成情况及其相关因素的系统评价和荟萃分析。
BMJ Open. 2022 Nov 21;12(11):e062461. doi: 10.1136/bmjopen-2022-062461.

引用本文的文献

1
Associations of night sleep duration and daytime napping with diabetic retinopathy in patients with type 2 diabetes.2型糖尿病患者夜间睡眠时间和日间小睡与糖尿病视网膜病变的关联。
Front Endocrinol (Lausanne). 2025 Jun 24;16:1565508. doi: 10.3389/fendo.2025.1565508. eCollection 2025.
2
Factors associated with knowledge of diabetic retinopathy among adults with diabetes on follow-up care at public hospitals in Addis Ababa, Ethiopia: an institution-based cross-sectional study.埃塞俄比亚亚的斯亚贝巴公立医院接受后续护理的成年糖尿病患者中与糖尿病视网膜病变知识相关的因素:一项基于机构的横断面研究。
Front Clin Diabetes Healthc. 2025 May 19;6:1527143. doi: 10.3389/fcdhc.2025.1527143. eCollection 2025.
3

本文引用的文献

1
Diabetic retinopathy incidence, predictors and its association with longitudinal fasting blood sugar level changes among diabetes mellitus patients in Ethiopia: joint model.糖尿病视网膜病变的发病率、预测因素及其与埃塞俄比亚糖尿病患者纵向空腹血糖水平变化的关系:联合模型。
Front Endocrinol (Lausanne). 2024 Jul 8;15:1363757. doi: 10.3389/fendo.2024.1363757. eCollection 2024.
2
Prevalence of diabetes mellitus among stroke patients in Ethiopia: Systematic review and meta-analysis.埃塞俄比亚中风患者中糖尿病的患病率:系统评价与荟萃分析。
Int J Cardiol Cardiovasc Risk Prev. 2024 May 17;21:200288. doi: 10.1016/j.ijcrp.2024.200288. eCollection 2024 Jun.
3
Aflibercept for the treatment of pigmentary retinopathy in Kearns-Sayre syndrome?
阿柏西普用于治疗卡恩斯-塞尔综合征的色素性视网膜病变?
Doc Ophthalmol. 2025 Jun;150(3):197-198. doi: 10.1007/s10633-025-10022-5. Epub 2025 May 20.
4
Genetic mechanisms of dynamic functional connectivity density in diabetic retinopathy brains: a combined transcriptomic and resting-state functional magnetic resonance imaging study.糖尿病视网膜病变患者大脑中动态功能连接密度的遗传机制:一项转录组学与静息态功能磁共振成像的联合研究
Front Cell Neurosci. 2025 Apr 10;19:1476038. doi: 10.3389/fncel.2025.1476038. eCollection 2025.
Prevalence and associated factors of proliferative diabetic retinopathy among adult diabetic patients in Northwest Ethiopia, 2023: A cross-sectional multicenter study.
2023 年,在埃塞俄比亚西北部成年糖尿病患者中增生性糖尿病视网膜病变的流行情况及相关因素:一项横断面多中心研究。
PLoS One. 2024 May 10;19(5):e0303267. doi: 10.1371/journal.pone.0303267. eCollection 2024.
4
Sight-threatening diabetic retinopathy and its predictors among patients with diabetes visiting Adare General Hospital in Southern Ethiopia: a hospital-based cross-sectional study.在埃塞俄比亚南部的 Adare 综合医院就诊的糖尿病患者中的威胁视力的糖尿病视网膜病变及其预测因素:一项基于医院的横断面研究。
BMJ Open. 2024 Feb 21;14(2):e077552. doi: 10.1136/bmjopen-2023-077552.
5
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review.撒哈拉以南非洲农村社区糖尿病患者的胰岛素治疗:一篇综述
Ther Adv Endocrinol Metab. 2024 Feb 19;15:20420188241232280. doi: 10.1177/20420188241232280. eCollection 2024.
6
The Role of Obesity in Type 2 Diabetes Mellitus-An Overview.肥胖在 2 型糖尿病中的作用——概述。
Int J Mol Sci. 2024 Feb 4;25(3):1882. doi: 10.3390/ijms25031882.
7
The incidence rate of tuberculosis and its associated factors among HIV-positive persons in Sub-Saharan Africa: a systematic review and meta-analysis.撒哈拉以南非洲地区 HIV 阳性人群中结核病的发病率及其相关因素:系统评价和荟萃分析。
BMC Infect Dis. 2023 Sep 18;23(1):613. doi: 10.1186/s12879-023-08533-0.
8
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.全球、地区和国家 1990 年至 2021 年糖尿病负担,以及对 2050 年患病率的预测:2021 年全球疾病负担研究的系统分析。
Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22.
9
Determinants of diabetic retinopathy in Ethiopia: A systematic review and meta-analysis.埃塞俄比亚糖尿病视网膜病变的决定因素:系统评价和荟萃分析。
PLoS One. 2023 Jun 8;18(6):e0286627. doi: 10.1371/journal.pone.0286627. eCollection 2023.
10
Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation.糖尿病视网膜病变是失明的主要原因以及一系列并发症的早期预测指标——风险与缓解措施。
EPMA J. 2023 Feb 13;14(1):21-42. doi: 10.1007/s13167-023-00314-8. eCollection 2023 Mar.